ImmunityBio
IBRX
$6.42
Share price
-2.87%
Change (1 day)
118.37%
Change (1 year)
Categories
Earnings for ImmunityBio (IBRX)
Earnings in 2023 (TTM): -$0.46 B
According to ImmunityBio's latest financial reports the company's current earnings (TTM) are -$0.47 B. In 2022 the company made an earning of -$0.36 B a decrease over its 2021 earnings that were of -$0.34 B.The earnings displayed on this page is the company's Pretax Income.
Earnings history for ImmunityBio from 2020 to 2023
Annual earnings
| Year | Earnings | Change |
|---|---|---|
2023 (TTM)  | -$0.46 B | 28.53% |
| 2022 | -$0.36 B | 5.61% |
| 2021 | -$0.34 B | 54.4% |
| 2020 | -$0.22 B |
Earnings for similar companies or competitors
| Company | Earnings | Earnings differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | -$0.12 B | -75.44% | 🇺🇸 USA |